Ganser A - Search Results

1

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

Wagner K, Damm F, Göhring G, Görlich K, Heuser M, Schäfer I, Ottmann O, Lübbert M, Heit W, Kanz L, Schlimok G, Raghavachar AA, Fiedler W, Kirchner HH, Brugger W, Zucknick M, Schlegelberger B, Heil G, Ganser A, Krauter J. Wagner K, et al. Among authors: ganser a. J Clin Oncol. 2010 May 10;28(14):2356-64. doi: 10.1200/JCO.2009.27.6899. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368538

2

Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: clinical implication.

Frisch J, Ganser A, Hoelzer D, Brugger W, Kanz L, Mertelsmann R, Schulz G. Frisch J, et al. Among authors: ganser a. Med Pediatr Oncol Suppl. 1992;2:34-7. doi: 10.1002/mpo.2950200709. Med Pediatr Oncol Suppl. 1992. PMID: 1306886 Clinical Trial.

3

A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias.

Lübbert M, Oster W, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F. Lübbert M, et al. Among authors: ganser a. Blood. 1992 Oct 15;80(8):2066-73. Blood. 1992. PMID: 1327288 Free article.

4

Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses.

Schardt C, Ottmann OG, Hoelzer D, Ganser A. Schardt C, et al. Among authors: ganser a. Leukemia. 1992 May;6(5):370-4. Leukemia. 1992. PMID: 1375695

5

Interleukin-3 in the treatment of myelodysplastic syndromes.

Ganser A, Ottmann OG, Hoelzer D. Ganser A, et al. Int J Clin Lab Res. 1992;22(3):125-8. doi: 10.1007/BF02591411. Int J Clin Lab Res. 1992. PMID: 1520908 Review.

6

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.

Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F, et al. Ganser A, et al. Blood. 1992 May 15;79(10):2583-91. Blood. 1992. PMID: 1586711 Free article. Clinical Trial.

7

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells.

Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S, Gillis S, Hoelzer D, Ganser A. Eder M, et al. Among authors: ganser a. Blood. 1992 Jun 15;79(12):3274-84. Blood. 1992. PMID: 1596568 Free article.

8

Treatment of relapsed or refractory adult acute lymphocytic leukemia.

Freund M, Diedrich H, Ganser A, Gramatzki M, Heil G, Heyll A, Henke M, Hiddemann W, Haas R, Kuse R, et al. Freund M, et al. Among authors: ganser a. Cancer. 1992 Feb 1;69(3):709-16. doi: 10.1002/1097-0142(19920201)69:3<709::aid-cncr2820690318>3.0.co;2-g. Cancer. 1992. PMID: 1730121

9

Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.

Herrmann F, Mertelsmann R, Lindemann A, Ottmann OG, Seipelt G, Oster W, Hoelzer D, Ganser A. Herrmann F, et al. Among authors: ganser a. Biotechnol Ther. 1991;2(3-4):299-311. Biotechnol Ther. 1991. PMID: 1845132 Clinical Trial.

10

Bone marrow findings after treatment with recombinant human interleukin-3.

Falk S, Seipelt G, Ganser A, Ottmann OG, Hoelzer D, Stutte HJ, Hübner K. Falk S, et al. Among authors: ganser a. Am J Clin Pathol. 1991 Mar;95(3):355-62. doi: 10.1093/ajcp/95.3.355. Am J Clin Pathol. 1991. PMID: 1996545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

888 results

Search Page

Filters